Minamestane

Minamestane (INN (former developmental code name FCE-24,928) is a steroidal aromatase inhibitor which was under development by Farmitalia-Carlo Erba as an antineoplastic agent in the mid-1990s but was never marketed.^[1][2][3]

ATC code

• None

CAS Number

• 105051-87-4

PubChem CID

• 65886

ChemSpider

• 59295

Quick facts Clinical data, ATC code ...

Minamestane

Clinical data
ATC code	None
Identifiers
IUPAC name 4-aminoandrosta-1,4,6-triene-3,17-dione
CAS Number	105051-87-4
PubChem CID	65886
ChemSpider	59295
UNII	J02058ABVE
CompTox Dashboard (EPA)	DTXSID40883152
Chemical and physical data
Formula	C19H23NO2
Molar mass	297.398 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C4\C=C/[C@]3(C(/C=C\[C@H]2[C@H]1[C@@](C(=O)CC1)(CC[C@@H]23)C)=C4/N)C
InChI InChI=1S/C19H23NO2/c1-18-10-8-15(21)17(20)14(18)4-3-11-12-5-6-16(22)19(12,2)9-7-13(11)18/h3-4,8,10-13H,5-7,9,20H2,1-2H3/t11-,12-,13-,18+,19-/m0/s1 Key:DAKHYLIFCYPHQW-KZQROQTASA-N

Close

Unlike other steroidal aromatase inhibitors such as formestane and exemestane, minamestane does not have androgenic properties.^[2]